Introduction
============

Radiotherapy is commonly used alone or in combination with genotoxic drugs for treatment of numerous solid tumors. Despite progress in its targeting, radiotherapy can be deleterious to two tissues, the gastrointestinal tract and the bone marrow (BM), and can lead to secondary effects commonly defined as Acute Radiation Syndrome.^[@b1-1051216]^ Irradiation of the BM damages hematopoietic stem and progenitor cells (HSPC) and perturbs the hematopoietic microenvironment,^[@b2-1051216],[@b3-1051216]^ resulting in radiation-induced acute myelosuppression^[@b4-1051216],[@b5-1051216]^ and increased susceptibility to infections.^[@b6-1051216],[@b7-1051216]^

Numerous types of DNA lesions are induced by cell exposure to ionizing radiation. They include base modifications, apurinic/apyrimidic sites (AP sites), and single- (SSB) and double (DSB)-strand breaks. DSB are the main lesions affecting cell survival. They can arise not only directly by deposition of energy on the DNA, but also as a consequence of the formation of AP sites or SSB.^[@b8-1051216],[@b9-1051216]^ Indeed, base excision repair (BER) activities, and in particular the processing of abasic sites, have been shown to contribute to radiation-induced DNA damage.^[@b10-1051216],[@b11-1051216]^

Apurinic/apyrimidic endonuclease-1 (Ape1) is the unique enzyme that converts AP sites into SSB intermediates during BER. Ape1 3'-phosphodieterase and -phosphate activities (for a review, see Laev *et al*.^[@b12-1051216]^) also contribute to the processing of radiation-induced DNA strand break extremities^[@b13-1051216]^ during the single strand break repair pathway (SSBR). Accordingly, protection of neuronal cells from radiation-induced damage requires Ape1.^[@b14-1051216],[@b15-1051216]^

The cellular prion protein (PrPC) is a highly conserved glycoprotein that, when structurally modified, plays a critical role in the pathogenesis of neurodegenerative disorders called prion diseases.^[@b16-1051216]^ The normal prion protein was shown to protect cells from oxidative stress.^[@b17-1051216]--[@b20-1051216]^ It also gives protection from DNA damage by promoting Ape1 DNA repair activity and cell survival through an interaction with Ape1.^[@b21-1051216]^ During hematopoiesis, PrPC is highly expressed in HSC and hematopoietic progenitors^[@b22-1051216]--[@b24-1051216]^ and PrPC deficiency is associated with decreased HSC self-renewal.^[@b25-1051216]^ As oxidative stress and DNA damage help determine HSC cell fate,^[@b26-1051216]^ PrPC might participate in the maintenance of the hematopoietic system and its response to cytotoxic stresses. To address these points, we used *Prnp* knockout mice to study the consequences of PrPC deficiency on hematopoiesis of young and old adult mice, and on the response of hematopoietic stem cells (HSC) and hematopoietic progenitors to gamma-irradiation.

Methods
=======

Mice
----

Mice experiments were carried out in compliance with the European Community Council Directive (EC/2010/63) and were approved by our institutional ethics committee (CetEA-CEA-DRF--n. 17-096). The B6.129S7-Prnptm1Cwe/Orl mice were from the European Mutant Mouse Archive and bred in our animal facility. We also used *Prnp* ZH3/ZH3 mice provided by A. Aguzzi (Zurich, Switzerland) and C57BL/6 mice were purchased from Charles River.

Cell sorting and flow cytometry analysis of bone marrow cells
-------------------------------------------------------------

Murine BM cells were flushed out of femurs, tibiae, hip bone and humeruses using a syringe filled with DPBS and filtered through a 70 μm-cell strainer. After red blood cell lysis using NH~4~Cl solution (STEMCELL Technologies), mononuclear cells were phenotyped using different antibody cocktails from Biolegend, e-Bioscience or Beckton Dickinson. Flow cytometry analysis was performed with a BD FACS LSRII^TM^ flow cytometer (BD Biosciences) and cell sorting with a FACS Influx cell sorter (Becton Dickinson). Data were analyzed with FlowJo software. Antibodies and gating strategies for hematopoietic subset analysis and sorting are described in the *Online Supplementary Methods*. For RT-PCR and Ape1 endonuclease activity experiments, aliquots of 50,000 myeloid progenitor cells were sorted in PBS whereas aliquots of 10,000 HSC and multi-potent progenitors (MPP) were sorted in PBS/1%BSA.

Ape1 endonuclease activity
--------------------------

Cell extracts were obtained by sonication of pelleted BM sorted cells in 20mM Tris-HCl, pH 7.5, 250mM NaCl, 1mM EDTA, 20mM sucrose, and protease inhibitor cocktail 0.1% (Sigma-Aldrich P2714). For progenitor analysis, 50,000 cells were suspended in 125 μL extraction buffer. For HSC or MEP analysis, 10,000 sorted cells were suspended in 30μL extraction buffer. After sonication, the homogenate was centrifuged at 20,000 × g for 30 minutes (min) at 4°C and aliquots of the supernatant were stored at −80°C. Ape1 endonuclease activity was measured using a 5'-end labeled 34-mer oligonucleotide containing a single tetrahydrofuranyl artificial AP site at position 16 hybridized to its complementary oligonucleotide containing a cytosine opposite the lesion (Eurogentec). To measure Ape1 activity in BM progenitors, 1-4 μL of cell extract were incubated for 30 min at 30°C in 10 μL of reaction buffer containing 25mM Tris-HCl pH 7.5, 5mM MgCl~2~, 5% glycerol, 52mM NaCl, BSA 1 μg/mL and 150 fmoles of the hybridized oligonucleotide. To determine Ape1 activity in BM HSC and MPP, 1-4 μL of cell extract were incubated for 10 min at 30°C in 10 μL reaction buffer containing 25mM Tris-HCl pH 7.5, 5mM MgCl2, 5% glycerol, 52mM NaCl, and 150 fmoles of the hybridized oligonucleotide. The reaction was stopped by adding 4μL of denaturating buffer (80% formamide, 0.1% bromophenol blue, 10mM EDTA) followed by heating for 5 min at 95°C. The products of the reaction were resolved by denaturating 7M urea-20% polyacrylamide gel electrophoresis. Gels were scanned using a Typhoon 5 (GE Healthcare Life Sciences) and band intensifies were quantified with ImageQuant TL 8.1 (GE Healthcare Life Sciences).

Statistical analyses
--------------------

Quantitative data are presented as the mean±standard error of mean (SEM). Statistical significance was assayed using the nonparametric Mann Whitney U-test (GraphPad Prism software).

Additional information concerning the materials and methods used are to be found in the *Online Supplementary Methods*.

Results
=======

Cellular prion protein is differentially expressed in hematopoietic stem cells and myeloid progenitors and is involved in hematopoietic stem cell expansion during aging
------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To address the potential functions of PrPC in hematopoietic stem and progenitor cells (HSPC), we first characterized the expression pattern of *Prnp* in different purified hematopoietic subpopulations, i.e. common myeloid progenitors (CMP), granulocyte-monocyte progenitors (GMP), megakaryocyte-erythrocyte progenitors (MEP), MPP, and hematopoietic stem cells (HSC). The highest level of *Prnp* mRNA was found in MEP while they were 2.7-fold and 4.3-fold lower in CMP and GMP, respectively ([Figure 1A](#f1-1051216){ref-type="fig"}). These differences in mRNA expression were also found at the protein level ([Figure 1B](#f1-1051216){ref-type="fig"} and *Online Supplementary Figure S1A*). The *Prnp* mRNA level in purified HSC was 2.5-fold higher than in MPP ([Figure 1C](#f1-1051216){ref-type="fig"}).

![PrPC contributes to mouse hematopoietic homeostasis. (A) quanta-tive real-time polymerase chain reaction (qRT-PCR) analysis of *Prnp* expression, normalized to *Rplp0* in the indicated bone marrow (BM) subpopulations: CMP: common myeloid progenitor; GMP: granulocyte-macrophage progenitor; MEP: megakaryocyte-erythrocyte progenitor purified by flow cytometry from BM of 3-month old mice (n=7-9). Data are presented as mean±standard error of mean (SEM). Means with different letters are significantly different (*P*\<0.05). (B) Flow cytometry analysis of the PrPC protein expression in the indicated BM supopulations. Graph depicts ratio of median fluorescence intensity (MFI) in wild-type (WT) and knock-out (KO) control cells (n=5-6). Data are presented as mean±SEM. Means with different letters are significantly different (*P*\<0.05) (CMP *vs*. MEP, *P*=0.06). (C) qRT-PCR analysis of *Prnp* expression, normalized to *Actb* in hematopoietic stem cell (HSC) (LSK CD135^−^) and in multipotent progenitor (MPP) (LSK CD135^+^) purified by flow cytometry from BM of 3-month old mice (n=9); Data are presented as mean±SEM. \*\*\**P*\<0.001. (D) Frequencies of myeloid progenitors in WT (black bars) and KO (white bars) BM from 3-month old mice (n=6-10). Data are presented as mean±SEM. \**P*\<0.05; \*\**P*\<0.01. (E) Frequencies of lymphoid progenitors (CLP), MPP, ST- and LT-HSC in the BM from WT (black bars) and KO (white bars) mice (n=6). Data are presented as mean±SEM. (F) Distribution of WT (black bars) and KO (white bars) HSC and MPP in each phase of the cell cycle. Data are presented as mean±SEM. \**P*\<0.05; \*\**P*\<0.01. ns: not significant. (G) *In vitro* plating efficiency of CMP and GMP purified by flow cytometry from BM of WT (black bars) and KO (white bars) mice (n=6-9). Data are presented as mean±SEM. \*\**P*\<0.01. (H) qRT-PCR analysis of *Prnp* expression, normalized to Actb in WT and KO HSC and MPP purified by flow cytometry from BM of 3-month and 11-month old mice (n=6-9). Data are presented as the mean±SEM. \*\*\**P*\<0.001 or ^\#\#\#^*P*\<0.001. (I) Frequencies of MPP, ST-and LT-HSC in BM from 3-month and 11-month old WT (black bars) and KO (white bars) mice. Data are presented as the mean±SEM fold change of the frequencies in 11-month relative to 3-month old mice (n=6-10). \*\**P*\<0.01 or ^\#\#^*P*\<0.01. (J) Ape1 endonuclease activity in 3-month (opened) and 11-month (hatched) old WT (dark) and KO (light) HSC. Data are presented as the mean±SEM. (n=4-5). \**P*\<0.05 or ^\#^*P*\<0.05. (K) qRT-PCR analysis of *Ape1* expression, normalized to *Actb* in WT (dark) and KO (light) HSC purified by flow cytometry from BM of 3-month (opened bars) and 11-month (hatched bars) old mice. Data are presented as mean±SEM. (n=7-9). \**P*\<0.05 or ^\#^*P*\<0.05.](1051216.fig1){#f1-1051216}

To determine if PrPC has a role in hematopoiesis, we first compared BM from 3-month old *Prnp*^+/+^ (WT) and *Prnp*^−/−^ (KO) mice. WT and KO mice showed similar peripheral blood counts (*data not shown*) and BM cellularity (*Online Supplementary Figure S1B*). However, the frequency of CMP, GMP and MEP was significantly reduced in KO mice compared to WT mice ([Figure 1D](#f1-1051216){ref-type="fig"}), whereas CLP, MPP, ST-HSC and LT-HSC frequencies were similar ([Figure 1E](#f1-1051216){ref-type="fig"}). The differences between KO and WT myeloid progenitor frequencies were not associated with increased apoptosis (*Online Supplementary Figure S1C)* or cell cycle alteration (*Online Supplementary Figure S1D*) but with a higher percentage of quiescent MPP and ST-HSC ([Figure 1F](#f1-1051216){ref-type="fig"}). These results suggest a defect of determination of HSPC (MPP and ST-HSC) towards the myeloid lineage in *Prnp*^−/−^ mice. Finally, clonogenic assay using purified CMP and GMP showed a significantly decreased plating efficiency of *Prnp*^−/−^ CMP and GMP ([Figure 1G](#f1-1051216){ref-type="fig"}). Taken together, these results show intrinsic myeloid differentiation deficiencies in *Prnp*^−/−^ HSC and progenitors and suggest that the reduction of cycling MPP and ST-HSC contributes to the lower myeloid progenitor content in the BM from KO compared to WT mice.

Aging of HSC is associated with an increased percentage of HSC in BM, decreased HSC self-renewal, and accumulation of DNA damage.^[@b27-1051216]^ As PrPC has been implicated in HSC self-renewal^[@b25-1051216]^ and in DNA repair,^[@b21-1051216]^ we investigated the effect of PrPC loss in HSC numbers and DNA repair capacity during aging in *Prnp^+/+^* and *Prnp^−/−^* mice. *Prnp* mRNA level in HSC was 2.7-fold higher in 11-month old compared to 3-month old mice ([Figure 1H](#f1-1051216){ref-type="fig"}) but did not change in MPP ([Figure 1H](#f1-1051216){ref-type="fig"}). BM from 11-month old WT and KO mice displayed similar cellularity (*Online Supplementary Figure S1E*). As in 3-month old mice, a lower frequency of myeloid progenitors but not MPP ([Figure 1I](#f1-1051216){ref-type="fig"}) was found in 11-month old KO mice (*Online Supplementary Figure S1F*). In contrast, compared to their 3-month old counterparts, ST- and LT-HSC frequencies respectively increased 2- and 8.3-fold in 11-month old WT mice but did not change (ST-HSC) or was only 3-fold increased (LT-HSC) in 11-month old KO mice ([Figure 1I](#f1-1051216){ref-type="fig"}). DNA repair was slightly dependent on PrPC in aged HSC. A 1.4-fold increased activity of Ape1 in WT HSC was found between three months and 11 months without any change in *Ape1* mRNA level. In KO HSC, Ape1 activity also increased between three months and 11 months, but to a lesser extent (1.2-fold) than in WT HSC. Interestingly, this increased activity was associated with an increased *Ape1* mRNA level ([Figure 1J and K](#f1-1051216){ref-type="fig"}).

Altogether, these results show that PrPC deficiency is associated with decreased HSC determination towards the myeloid lineage, and decreased number of HSC and decreased Ape1 activity in old mice.

*Prnp* expression is up-regulated in myeloid progenitors and hematopoietic stem cell subpopulations after *in vivo* radiation exposure
--------------------------------------------------------------------------------------------------------------------------------------

Hematopoietic stem cell aging is associated with increased oxidative stress^[@b28-1051216]^ and PrPC has been shown to protect cells from oxidative stress.^[@b17-1051216]--[@b20-1051216]^ To characterize the role of PrPC during the oxidative stress of hematopoiesis, we performed total body irradiation (TBI) on WT and KO mice. Survival curves of WT and KO mice exposed to increasing gamma-radiation doses showed that a higher percentage of irradiated KO mice died earlier than irradiated WT mice even if statistical significance between both genotypes was not reached (*P*=0.0792 at 7 Gy) ([Figure 2A](#f2-1051216){ref-type="fig"}). When KO mice were grafted with BM from non-irradiated WT mice 24 hours (h) after a 7 Gy irradiation, they did not die, indicating that the higher sensitivity of KO mice to TBI was not due to the BM microenvironment of KO mice and that they died from hematopoietic syndrome.

![PrPC favors survival of mice exposed to moderate doses of γ-rays and protects common myeloid progenitors (CMP) from radiation-induced death. (A) Kaplan-Meier survival plots of wild-type (WT) (solid lines) and knock-out (KO) (dashed lines) mouse overall survival after total body irradiation (TBI) at indicated doses: n=5, 10 Gy; n=13, 6.5 Gy; n=28, 7 Gy; for each genotype. Arrow points to the 100% survival of both KO and WT irradiated mice (7 Gy) after transplantation of WT bone marrow (BM) cells (n=5). (B) Quantitative real-time polymerase chain reaction (qRT-PCR) analysis of *Prnp* expression in hematopoietic stem cell (HSC), multi-potent progenitor (MPP), and myeloid progenitors 1 hour (h) after irradiation (7 Gy) (n=6). *Prnp* RNA levels were normalized to *Actb* (HSC and MPP) or *Rplp0* (myeloid progenitors). Data are presented as mean±standard error of mean (SEM) fold change of normalized *Prnp* RNA levels in irradiated relative (IR) to control cells (Ctrl). \**P*\<0.05; \*\**P*\<0.01. (C) Ape1 endonuclease activity in myeloid progenitor subpopulations from WT (black bars) and KO (white bars) mice (n=5-8). Data are presented as mean±SEM. Means with different letters are significantly different (*P*\<0.05). (D) Ape1 endonuclease activity in myeloid progenitors from WT (black bars) and KO (white bars) mice (n=5-8) 1 h after irradiation (7 Gy). Data are presented as mean±SEM fold change of Ape1 endonuclease in irradiated relative to non-irradiated control cells. \**P*\<0.05; \*\**P*\<0.01. (E) Ape1 endonuclease activity in HSC and MPP from WT (black bars) and KO (white bars) mice (n=5-8). Data are presented as mean±SEM. (F) Ape1 endonuclease activity in HSC and MPP from WT (black bars) and KO (white bars) mice (n=4-5) 1 h after irradiation (7 Gy). Data are presented as mean±SEM fold change of Ape1 endonuclease in irradiated relative to non-irradiated control cells. \**P*\<0.05 or ^\#^*P*\<0.05. (G) Percentage of apoptotic myeloid progenitors (AnnexineV-positive cells) in BM from WT (black bars) and KO (white bars) mice (n=6-8) 1 h after irradiation (7 Gy). Data are presented as mean±SEM fold change of percentage of apoptotic cells in irradiated relative to non-irradiated control myeloid progenitors. \*\**P*\<0.01; \*\*\*P\<0.001; ^\#^*P*\<0.05. (H) Percentage of apoptotic myeloid progenitors (AnnexineV-positive cells) in BM from WT (dark gray bars, WTIR) and KO (light gray bars, KOIR) mice (n=6-8) 1 h after irradiation (7 Gy). Data are presented as mean±SEM. Non-irradiated control WT (black bars) and KO (white bars) myeloid progenitors are shown. \*\**P*\<0.01; ^\#^*P*\<0.05. (I) Percentage of myeloid progenitors in BM from WT (black bars) and KO (white bars) mice (n=6-7) 18 h after irradiation (7 Gy). Data are presented as mean±SEM of the percentage of cells remaining in BM 18 h after irradiation compared to non-irradiated control. \*\**P*\<0.01.](1051216.fig2){#f2-1051216}

One hour after a 7 Gy TBI, a 1.5-fold increase in *Prnp* mRNA level was found in HSC, CMP and GMP but not in MPP and MEP ([Figure 2B](#f2-1051216){ref-type="fig"}). These data are consistent with the observed *Prnp* upregulation in neuronal tissues after exposure to genotoxic stress,^[@b21-1051216]^ and suggest a potential role of PrPC in response to radiation in GMP, CMP, and HSC.

Cellular prion protein-dependent increase in the DNA repair activity of Ape1 is associated with radioprotection of CMP and GMP
------------------------------------------------------------------------------------------------------------------------------

Cellular prion protein prevents cell death in response to alkylating agent or H~2~O~2~ exposure by directly stimulating the DNA repair activity of Ape1.^[@b21-1051216]^ Without irradiation, Ape1 activity was similar in WT and KO progenitors ([Figure 2C](#f2-1051216){ref-type="fig"}). One hour after a 7 Gy TBI, Ape1 activity increased in all WT irradiated myeloid progenitors analyzed (from 1.5- to 1.7-fold) but not in their KO counter parts ([Figure 2D](#f2-1051216){ref-type="fig"}). In HSC and MPP, Ape1 activity was similar in WT and KO mice ([Figure 2E](#f2-1051216){ref-type="fig"}) but increased only in WT HSC after a 7 Gy TBI ([Figure 2F](#f2-1051216){ref-type="fig"}). Whatever the subpopulation analyzed, the radiation-induced Ape1 activity was not associated with an increase in *Ape1* mRNA level (*Online Supplementary Figure S2A and B*). These data show that, after irradiation, Ape1 activity in all myeloid progenitor subpopulations and in HSC is stimulated in a PrPC-dependent manner.

As the radiation-induced death of myeloid progenitors is dependent on apoptosis,^[@b5-1051216]^ we quantified apoptosis in WT and KO myeloid progenitors 1 and 12 h after TBI at 7 Gy. One hour after irradiation, apoptotic (Annexin V-positive cells) and dead cell (Annexin V-negative and Hoechst-positive cells) fractions increased only in CMP and were higher in KO compared to WT CMP ([Figure 2G](#f2-1051216){ref-type="fig"} and *Online Supplementary Figure S2C*). Twelve hours after irradiation, both apoptotic ([Figure 2H](#f2-1051216){ref-type="fig"}) and dead (*Online Supplementary Figure S2D*) cell fractions increased in all myeloid progenitor subpopulations in both WT and KO mice. However, higher rates of apoptosis and cellular death were observed in irradiated KO compared to WT GMP. In accordance with this, significantly lower frequencies of CMP and GMP were found in KO *versus* WT irradiated mice 18 h after irradiation ([Figure 2I](#f2-1051216){ref-type="fig"}). Myeloid progenitors from *Prnp* ZH3/ZH3 mice exhibited the same radiation sensitivity than those from *Prnp*^−/−^ mice, shown by a similar reduced number compared to mice in non-irradiated conditions (*Online Supplementary Figure S2E*). Altogether, these results suggest that PrPC-dependent stimulation of the DNA repair activity of Ape1 is required for the radioprotection of myeloid progenitors.

Discussion
==========

Despite numerous studies, the physiological role of PrPC remains elusive. Recently, we showed that PrPC can stimulate an important DNA repair pathway, the BER, in neuronal tissues through interaction with and stimulation of its key enzyme, APE1.^[@b21-1051216]^ Here we show that the same mechanism can be proposed for the radioprotection of myeloid progenitors, HSC determination, and the expansion of the HSC compartment during aging.

Previous studies^[@b22-1051216]--[@b24-1051216],[@b29-1051216]^ indicated a decreased *Prnp* expression during differentiation of hematopoietic cells. Here, we performed an extended study of *Prnp* expression in different hematopoietic subpopulations and showed a 3-fold higher *Prnp* expression level in MEP compared to their progenitors CMP, suggesting that the correlation between *Prnp* downregulation and cellular differentiation^[@b24-1051216]^ may not be a general feature in hematopoiesis. Furthermore, and contrary to a previous study,^[@b25-1051216]^ we found that KO mice have less myeloid progenitors. This discrepancy could be explained by the fact that, in the previous study, younger mice were analyzed (7-10-week old mice compared to the 3-month and 11-month old mice used in the present study) and by the number of backcrosses (4 *vs*. \>10) that might influence the phenotype of *Prnp* knockout mice.^[@b30-1051216]^ Finally, we found a higher frequency of KO ST-HSC and KO MPP in the G0 phase. These populations being the direct precursors of myeloid progenitors, the increased quiescence of these cells might account for the decreased myeloid progenitor subpopulations.^[@b31-1051216]^ Strikingly, both KO CMP and GMP exhibited a lower plating efficiency despite no significant change in their cell cycle *in vivo*. Whether the microenvironment of these cells could compensate *in vivo* for an intrinsic growth deficiency observed *in vitro* remains to be clarified.

*Prnp* expression in the HSC compartment increased 8-fold with age. This higher expression was associated with the known elevated frequency of both ST- and LT-HSC.^[@b27-1051216],[@b32-1051216]^ PrPC deficiency was associated with no increase in ST-HSC and with a diminished increase in LT-HSC with age, suggesting that PrPC plays a role in the age-dependent increase in HSC. Although an aging-associated increase in HSC numbers has been known for a long time and is known to be cell-intrinsic,^[@b33-1051216],[@b34-1051216]^ the underlying mechanisms are not fully understood. The results presented here indicate a significant involvement of PrPC in the age-dependent increase in HSC frequency. This increase may be accounted for by a PrPC-dependent upregulation of Ape1 repair activity. Independently of its DNA repair activity,^[@b35-1051216],[@b36-1051216]^ Ape1 has a redox activity shown to be necessary for normal embryonic hematopoiesis,^[@b37-1051216]^ stem cell pool maintenance,^[@b38-1051216],[@b39-1051216]^ and hematopoietic progenitor colony formation.^[@b40-1051216]^ Thus, the PrPC-dependent stimulation of the Ape1 DNA repair activity might contribute to hematopoietic homeostasis.

We found a modest but recurrent radiation sensitization of *Prnp* KO mice that contrasts with a previous study showing that the absence of PrPC protected rather than sensitized mice to an 8 Gy TBI.^[@b41-1051216]^ However, this work was performed on a mixed 129/C57BL6 background, whereas we used a pure C57BL6 background. Furthermore, that study used a dose of X rays that was lethal for WT animals, while we used different doses of non-lethal γ-rays. BM myeloid cells are particularly sensitive to chemical and radiation cytotoxicity.^[@b4-1051216],[@b42-1051216],[@b43-1051216]^ Accordingly, we found a dramatic decrease in BM myeloid progenitors within the first 24 h after radiation exposure that was exacerbated in *Prnp* KO irradiated mice. The reduced frequency of KO irradiated myeloid progenitors was associated with higher CMP and GMP apoptosis, within the first 12 h after irradiation, as well as with an absence of stimulation of Ape1 activity in these subpopulations 1 h after irradiation. In contrast, in WT irradiated myeloid progenitors and HSC, upregulation of *Prnp* gene expression was associated with an increase in Ape1 activity in these subpopulations. PrPC has been shown to protect HSC from myelotoxic injury by 5-FU, commonly used in chemotherapy,^[@b25-1051216]^ and we now extend its myeloprotective role to radiotherapy.

Finally, a similar basal reduced number of myeloid progenitors and a similar radiation sensitivity of myeloid progenitors were found in the co-isogenic *Prnp*^ZH3/ZH3^ mouse line^[@b44-1051216]^ and the *Prnp^−/−^* mouse line. These results rule out the involvement of any *Prnp* flanking gene polymorphism previously described by Nuvolone *et al*.^[@b45-1051216]^

Altogether, these results suggest that PrPC is involved in the homeostasis of steady-state hematopoiesis and that PrPC-dependent activation of base excision repair contributes to the radioprotection of the myeloid progenitors of the mouse bone marrow.
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